Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA).
about
Homing in on the hepatic scar: recent advances in cell-specific targeting of liver fibrosisModern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targetsEnhanced effectivity of an ALK5-inhibitor after cell-specific delivery to hepatic stellate cells in mice with liver injuryEffectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice ModelIdentification of the insulin-like growth factor II receptor as a novel receptor for binding and invasion by Listeria monocytogenes.Arg-gly-asp-mannose-6-phosphate inhibits activation and proliferation of hepatic stellate cells in vitro.Bioconjugation of oligonucleotides for treating liver fibrosis.HPMA polymer-based site-specific delivery of oligonucleotides to hepatic stellate cells.Experimental liver fibrosis research: update on animal models, legal issues and translational aspects.Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor.Specific delivery of kinase inhibitors in nonmalignant and malignant diseases.Novel materials which possess the ability to target liver cells.Albumin-drug conjugates in the treatment of hepatic disorders.Liver cell-targeted delivery of therapeutic molecules.Nanomedicines in gastroenterology and hepatology.Receptor-mediated hepatic uptake of M6P-BSA-conjugated triplex-forming oligonucleotides in rats.Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model.Nanoparticles for the treatment of liver fibrosis.Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated.Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632.Mannose 6-phosphate-modified bovine serum albumin nanoparticles for controlled and targeted delivery of sodium ferulate for treatment of hepatic fibrosis.Addressing liver fibrosis with liposomes targeted to hepatic stellate cells.
P2860
Q26742049-49534989-773F-48E7-A9D1-5700926C1D3BQ28303698-0E18E83C-DD95-4752-AA8C-D8B866B095B2Q28486225-936B76AD-1150-4B9A-B4BD-6D26DBF915A7Q28551990-61D740F1-9A15-4183-A515-140BFB93B916Q33230045-6A2C3B94-9907-428C-928B-66A35034B3CBQ33236349-11653C2A-9259-45CC-8AC5-F110B99D7533Q37043515-0B762652-C530-473D-9D11-F8912C9B3906Q37192499-C94A2110-A1B2-44FB-B6E0-39951D538ABEQ37363773-81878CFD-707D-454A-A024-2C1A07A8F704Q37641786-76CAE56E-EBB8-4CDC-92D9-CBCB6778EC07Q37960141-5702C1E5-0992-4EDC-9582-74421BA6A09FQ38000319-C150217D-42BD-456E-80F0-823220776388Q38207699-9781E662-5623-4E5B-BC60-572CE4EADA3BQ38229624-3C902FB2-5D64-413F-916F-C62717A2F9C7Q38370747-3C41201B-6D39-4E24-B09D-FC43C1E268ADQ39252175-A878DB74-3F7D-413A-978B-AD3B69E671B3Q40150894-80335731-0311-4901-B278-4CDBE873E192Q42364467-44CB3879-FF51-49DB-8AAB-3B33A00AFEADQ42583288-CAE39533-2AA2-4BAB-A831-8AF8F1E1CE29Q42789129-33209B93-9B48-435D-8B74-511130899C76Q43287008-A950FA12-0B72-42CB-9CF4-FE7A0A67DC13Q46890423-5A650C96-92A1-45B4-B324-0618CEDEFE68
P2860
Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA).
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Characteristics of the hepatic ...... odified albumin (M6P(28)-HSA).
@en
Characteristics of the hepatic ...... e 6-phosphate modified albumin
@nl
type
label
Characteristics of the hepatic ...... odified albumin (M6P(28)-HSA).
@en
Characteristics of the hepatic ...... e 6-phosphate modified albumin
@nl
prefLabel
Characteristics of the hepatic ...... odified albumin (M6P(28)-HSA).
@en
Characteristics of the hepatic ...... e 6-phosphate modified albumin
@nl
P2093
P2860
P1433
P1476
Characteristics of the hepatic ...... odified albumin (M6P(28)-HSA).
@en
P2093
Beljaars L
Groothuis GM
Poelstra K
de Bleser P
P2860
P304
P356
10.1034/J.1600-0676.2001.210504.X
P577
2001-10-01T00:00:00Z